BioSpace News Archive

TG Therapeutics, Inc., announced the schedule of upcoming data presentations at the 16th International Congress on Malignant Lymphoma, being held virtually June 18 – 22, 2021.

CTI BioPharma Corp. announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:30 p.m. ET.

The global healthcare systems are undergoing a vibrant change, where patient centric are replacing conventional reactive care model consistently.

Caraway Therapeutics announced an exclusive, collaboration and option agreement with AbbVie to develop and commercialize Caraway’s small molecule therapeutics targeting TMEM175, a potassium ion channel critical to lysosomal function implicated in both Parkinson’s disease and other neurodegenerative disorders.

Magellan Rx Management, a division of Magellan Health, Inc., announced annualized savings of over $40 million for five health plan customers who were early adopters of its oncology biosimilar medical benefit drug management solution.

Engineered TACs Prevented Hyperglycemia in Type 1 Diabetes Models by Deletion of Target T Cells and Increase of Regulatory T Cells that Exerted Potent Bystander Suppression

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, announced that company management will participate in the following upcoming investor conferences

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that Mr. Adi Frish, RedHill’s Chief Corporate & Business Development Officer, will present a corporate overview at the BIO Digital International Convention, taking place June 14-18, 2021.

Alcyone’s proprietary CNS precision delivery and dosing platform enables unprecedented control and versatility for CNS biodistribution and gene therapy development

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that nine abstracts have been selected for virtual presentation, including one oral presentation, at the upcoming European Hematology Association 2021 Virtual Congress taking place June 9-17, 2021.